In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
In April, the Society of Radiologists in Ultrasound released a consensus statement outlining recommendations for healthcare providers with the goal of improving the imaging, detection, and evaluation of...
In this COVID-19 roundup, researchers report on an increase in outpatient care following COVID-19 infection, cognition and memory impairment among those recovering from COVID-19, and more.
A systematic review and meta-analysis examined the clinical differences between adult patients with neuromyelitis optica spectrum disorders and those with multiple sclerosis.
Gynecologic oncologists currently lack risk models that can accurately predict an endometrial cancer diagnosis at the time of hysterectomy for endometrial intraepithelial neoplasia. To fill this gap,...
Researchers developed a retrospective cohort study to examine the reoperation rates and health care costs associated with reoperation for patients who underwent breast-conserving surgery.
Researchers examined the characteristics and trends related to the increased mortality rates associated with overdose in pregnant and postpartum women.
In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.